Mutation
The putative cancer-causing PDGs driven by somatic mutations were predicted by integration of five complementary methods to identify the genes with mutations that have significant signs of positive selection during tumor evolution.
| Showing page 54 |
first page | previous page | next page | last page |
| HGNC Symbol | Ensembl Gene ID | Overall_Mscore | No. of Cancer Types |
| LRRN1 | ENSG00000175928 | 0.00 | 0 |
| SLC15A2 | ENSG00000163406 | 0.00 | 0 |
| FGFRL1 | ENSG00000127418 | 0.00 | 0 |
| SLC2A9 | ENSG00000109667 | 0.00 | 0 |
| GABRA2 | ENSG00000151834 | 0.00 | 0 |
| AREG | ENSG00000109321 | 0.00 | 0 |
| ADAM19 | ENSG00000135074 | 0.00 | 0 |
| NCR3 | ENSG00000204475 | 0.00 | 0 |
| PI16 | ENSG00000164530 | 0.00 | 0 |
| SLC22A16 | ENSG00000004809 | 0.00 | 0 |
| SLC12A9 | ENSG00000146828 | 0.00 | 0 |
| SLC26A5 | ENSG00000170615 | 0.00 | 0 |
| AQP3 | ENSG00000165272 | 0.00 | 0 |
| SLC44A1 | ENSG00000070214 | 0.00 | 0 |
| NEGR1 | ENSG00000172260 | 0.00 | 0 |
| BST1 | ENSG00000109743 | 0.00 | 0 |
| HHIP | ENSG00000164161 | 0.00 | 0 |
| OPCML | ENSG00000183715 | 0.00 | 0 |
| TFPI | ENSG00000003436 | 0.00 | 0 |
| NID2 | ENSG00000087303 | 0.00 | 0 |
|
Showing page 54 |
first page | previous page | next page | last page |